FIGURE 2.

Analytic framework reflecting emerging science, knowledge gaps, and research needs for the pathway from universal screening of asymptomatic pregnant women and young children 6–24 mo (including routine iron supplementation) to relevant health outcomes as conceptualized by using discussions that took place throughout the workshop on screening and supplementation of iron-replete pregnant women and young children (1). Solid lines reflect pathway components supported by current evidence; dashed lines reflect pathway components suggested by emerging evidence or indicative of gaps in our knowledge for which additional research is needed. GDM, gestational diabetes mellitus; GI, gastrointestinal; ID, iron deficiency; IDA, iron deficiency anemia; T2D, type 2 diabetes.